世界のアカラブルチニブ市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Acalabrutinib Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3749
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、88ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、アカラブルチニブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バイオ医薬品用、実験室用）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・アカラブルチニブの市場動向
・企業の競争状況、市場シェア
・アカラブルチニブの種類別市場規模と予測2016-2027（バイオ医薬品用、実験室用）
・アカラブルチニブの用途別市場規模と予測2016-2027（病院、診療所、その他）
・アカラブルチニブの北米市場規模2016-2027（アメリカ、カナダ）
・アカラブルチニブの欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・アカラブルチニブのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・アカラブルチニブの中南米市場規模2016-2027（メキシコ、ブラジル）
・アカラブルチニブの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AstraZeneca Pharmaceuticals LP、Cephalon, Inc、Genentech, Inc、Cayman Chemical Company）
・結論

Acalabrutinib (ACP-196) is an orally active, irreversible, and highly selective second-generation BTK inhibitor. Acalabrutinib binds covalently to Cys481 in the ATP-binding pocket of BTK. Acalabrutinib demonstrates potent on-target effects and efficacy in mouse models of chronic lymphocytic leukemia (CLL).

Market Analysis and Insights: Global Acalabrutinib Market
The global Acalabrutinib market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acalabrutinib market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acalabrutinib market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acalabrutinib market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acalabrutinib market.

Global Acalabrutinib Scope and Market Size
Acalabrutinib market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acalabrutinib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Biopharmaceutical Grade
Laboratory Grade

Segment by Application
Hospital
Clinic
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca Pharmaceuticals LP
Cephalon, Inc
Genentech, Inc
Cayman Chemical Company

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acalabrutinib Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Biopharmaceutical Grade
1.2.3 Laboratory Grade
1.3 Market by Application
1.3.1 Global Acalabrutinib Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acalabrutinib Market Perspective (2016-2027)
2.2 Acalabrutinib Growth Trends by Regions
2.2.1 Acalabrutinib Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acalabrutinib Historic Market Share by Regions (2016-2021)
2.2.3 Acalabrutinib Forecasted Market Size by Regions (2022-2027)
2.3 Acalabrutinib Industry Dynamic
2.3.1 Acalabrutinib Market Trends
2.3.2 Acalabrutinib Market Drivers
2.3.3 Acalabrutinib Market Challenges
2.3.4 Acalabrutinib Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acalabrutinib Players by Revenue
3.1.1 Global Top Acalabrutinib Players by Revenue (2016-2021)
3.1.2 Global Acalabrutinib Revenue Market Share by Players (2016-2021)
3.2 Global Acalabrutinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acalabrutinib Revenue
3.4 Global Acalabrutinib Market Concentration Ratio
3.4.1 Global Acalabrutinib Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acalabrutinib Revenue in 2020
3.5 Acalabrutinib Key Players Head office and Area Served
3.6 Key Players Acalabrutinib Product Solution and Service
3.7 Date of Enter into Acalabrutinib Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acalabrutinib Breakdown Data by Type
4.1 Global Acalabrutinib Historic Market Size by Type (2016-2021)
4.2 Global Acalabrutinib Forecasted Market Size by Type (2022-2027)

5 Acalabrutinib Breakdown Data by Application
5.1 Global Acalabrutinib Historic Market Size by Application (2016-2021)
5.2 Global Acalabrutinib Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acalabrutinib Market Size (2016-2027)
6.2 North America Acalabrutinib Market Size by Type
6.2.1 North America Acalabrutinib Market Size by Type (2016-2021)
6.2.2 North America Acalabrutinib Market Size by Type (2022-2027)
6.2.3 North America Acalabrutinib Market Size by Type (2016-2027)
6.3 North America Acalabrutinib Market Size by Application
6.3.1 North America Acalabrutinib Market Size by Application (2016-2021)
6.3.2 North America Acalabrutinib Market Size by Application (2022-2027)
6.3.3 North America Acalabrutinib Market Size by Application (2016-2027)
6.4 North America Acalabrutinib Market Size by Country
6.4.1 North America Acalabrutinib Market Size by Country (2016-2021)
6.4.2 North America Acalabrutinib Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Acalabrutinib Market Size (2016-2027)
7.2 Europe Acalabrutinib Market Size by Type
7.2.1 Europe Acalabrutinib Market Size by Type (2016-2021)
7.2.2 Europe Acalabrutinib Market Size by Type (2022-2027)
7.2.3 Europe Acalabrutinib Market Size by Type (2016-2027)
7.3 Europe Acalabrutinib Market Size by Application
7.3.1 Europe Acalabrutinib Market Size by Application (2016-2021)
7.3.2 Europe Acalabrutinib Market Size by Application (2022-2027)
7.3.3 Europe Acalabrutinib Market Size by Application (2016-2027)
7.4 Europe Acalabrutinib Market Size by Country
7.4.1 Europe Acalabrutinib Market Size by Country (2016-2021)
7.4.2 Europe Acalabrutinib Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acalabrutinib Market Size (2016-2027)
8.2 Asia-Pacific Acalabrutinib Market Size by Type
8.2.1 Asia-Pacific Acalabrutinib Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acalabrutinib Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acalabrutinib Market Size by Type (2016-2027)
8.3 Asia-Pacific Acalabrutinib Market Size by Application
8.3.1 Asia-Pacific Acalabrutinib Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acalabrutinib Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acalabrutinib Market Size by Application (2016-2027)
8.4 Asia-Pacific Acalabrutinib Market Size by Region
8.4.1 Asia-Pacific Acalabrutinib Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acalabrutinib Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acalabrutinib Market Size (2016-2027)
9.2 Latin America Acalabrutinib Market Size by Type
9.2.1 Latin America Acalabrutinib Market Size by Type (2016-2021)
9.2.2 Latin America Acalabrutinib Market Size by Type (2022-2027)
9.2.3 Latin America Acalabrutinib Market Size by Type (2016-2027)
9.3 Latin America Acalabrutinib Market Size by Application
9.3.1 Latin America Acalabrutinib Market Size by Application (2016-2021)
9.3.2 Latin America Acalabrutinib Market Size by Application (2022-2027)
9.3.3 Latin America Acalabrutinib Market Size by Application (2016-2027)
9.4 Latin America Acalabrutinib Market Size by Country
9.4.1 Latin America Acalabrutinib Market Size by Country (2016-2021)
9.4.2 Latin America Acalabrutinib Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acalabrutinib Market Size (2016-2027)
10.2 Middle East & Africa Acalabrutinib Market Size by Type
10.2.1 Middle East & Africa Acalabrutinib Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acalabrutinib Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acalabrutinib Market Size by Type (2016-2027)
10.3 Middle East & Africa Acalabrutinib Market Size by Application
10.3.1 Middle East & Africa Acalabrutinib Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acalabrutinib Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acalabrutinib Market Size by Application (2016-2027)
10.4 Middle East & Africa Acalabrutinib Market Size by Country
10.4.1 Middle East & Africa Acalabrutinib Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acalabrutinib Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca Pharmaceuticals LP
11.1.1 AstraZeneca Pharmaceuticals LP Company Details
11.1.2 AstraZeneca Pharmaceuticals LP Business Overview
11.1.3 AstraZeneca Pharmaceuticals LP Acalabrutinib Introduction
11.1.4 AstraZeneca Pharmaceuticals LP Revenue in Acalabrutinib Business (2016-2021)
11.1.5 AstraZeneca Pharmaceuticals LP Recent Development
11.2 Cephalon, Inc
11.2.1 Cephalon, Inc Company Details
11.2.2 Cephalon, Inc Business Overview
11.2.3 Cephalon, Inc Acalabrutinib Introduction
11.2.4 Cephalon, Inc Revenue in Acalabrutinib Business (2016-2021)
11.2.5 Cephalon, Inc Recent Development
11.3 Genentech, Inc
11.3.1 Genentech, Inc Company Details
11.3.2 Genentech, Inc Business Overview
11.3.3 Genentech, Inc Acalabrutinib Introduction
11.3.4 Genentech, Inc Revenue in Acalabrutinib Business (2016-2021)
11.3.5 Genentech, Inc Recent Development
11.4 Cayman Chemical Company
11.4.1 Cayman Chemical Company Company Details
11.4.2 Cayman Chemical Company Business Overview
11.4.3 Cayman Chemical Company Acalabrutinib Introduction
11.4.4 Cayman Chemical Company Revenue in Acalabrutinib Business (2016-2021)
11.4.5 Cayman Chemical Company Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acalabrutinib Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Biopharmaceutical Grade
Table 3. Key Players of Laboratory Grade
Table 4. Global Acalabrutinib Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Acalabrutinib Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Acalabrutinib Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Acalabrutinib Market Share by Regions (2016-2021)
Table 8. Global Acalabrutinib Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Acalabrutinib Market Share by Regions (2022-2027)
Table 10. Acalabrutinib Market Trends
Table 11. Acalabrutinib Market Drivers
Table 12. Acalabrutinib Market Challenges
Table 13. Acalabrutinib Market Restraints
Table 14. Global Acalabrutinib Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Acalabrutinib Market Share by Players (2016-2021)
Table 16. Global Top Acalabrutinib Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acalabrutinib as of 2020)
Table 17. Ranking of Global Top Acalabrutinib Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Acalabrutinib Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Acalabrutinib Product Solution and Service
Table 21. Date of Enter into Acalabrutinib Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Acalabrutinib Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Acalabrutinib Revenue Market Share by Type (2016-2021)
Table 25. Global Acalabrutinib Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Acalabrutinib Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Acalabrutinib Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Acalabrutinib Revenue Market Share by Application (2016-2021)
Table 29. Global Acalabrutinib Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Acalabrutinib Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Acalabrutinib Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Acalabrutinib Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Acalabrutinib Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Acalabrutinib Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Acalabrutinib Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Acalabrutinib Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Acalabrutinib Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Acalabrutinib Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Acalabrutinib Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Acalabrutinib Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Acalabrutinib Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Acalabrutinib Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Acalabrutinib Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Acalabrutinib Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Acalabrutinib Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Acalabrutinib Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Acalabrutinib Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Acalabrutinib Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Acalabrutinib Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Acalabrutinib Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Acalabrutinib Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Acalabrutinib Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Acalabrutinib Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Acalabrutinib Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Acalabrutinib Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Acalabrutinib Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Acalabrutinib Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Acalabrutinib Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Acalabrutinib Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Acalabrutinib Market Size by Country (2022-2027) & (US$ Million)
Table 61. AstraZeneca Pharmaceuticals LP Company Details
Table 62. AstraZeneca Pharmaceuticals LP Business Overview
Table 63. AstraZeneca Pharmaceuticals LP Acalabrutinib Product
Table 64. AstraZeneca Pharmaceuticals LP Revenue in Acalabrutinib Business (2016-2021) & (US$ Million)
Table 65. AstraZeneca Pharmaceuticals LP Recent Development
Table 66. Cephalon, Inc Company Details
Table 67. Cephalon, Inc Business Overview
Table 68. Cephalon, Inc Acalabrutinib Product
Table 69. Cephalon, Inc Revenue in Acalabrutinib Business (2016-2021) & (US$ Million)
Table 70. Cephalon, Inc Recent Development
Table 71. Genentech, Inc Company Details
Table 72. Genentech, Inc Business Overview
Table 73. Genentech, Inc Acalabrutinib Product
Table 74. Genentech, Inc Revenue in Acalabrutinib Business (2016-2021) & (US$ Million)
Table 75. Genentech, Inc Recent Development
Table 76. Cayman Chemical Company Company Details
Table 77. Cayman Chemical Company Business Overview
Table 78. Cayman Chemical Company Acalabrutinib Product
Table 79. Cayman Chemical Company Revenue in Acalabrutinib Business (2016-2021) & (US$ Million)
Table 80. Cayman Chemical Company Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acalabrutinib Market Share by Type: 2020 VS 2027
Figure 2. Biopharmaceutical Grade Features
Figure 3. Laboratory Grade Features
Figure 4. Global Acalabrutinib Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Acalabrutinib Report Years Considered
Figure 9. Global Acalabrutinib Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Acalabrutinib Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Acalabrutinib Market Share by Regions: 2020 VS 2027
Figure 12. Global Acalabrutinib Market Share by Regions (2022-2027)
Figure 13. Global Acalabrutinib Market Share by Players in 2020
Figure 14. Global Top Acalabrutinib Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acalabrutinib as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Acalabrutinib Revenue in 2020
Figure 16. Global Acalabrutinib Revenue Market Share by Type (2016-2021)
Figure 17. Global Acalabrutinib Revenue Market Share by Type (2022-2027)
Figure 18. North America Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Acalabrutinib Market Share by Type (2016-2027)
Figure 20. North America Acalabrutinib Market Share by Application (2016-2027)
Figure 21. North America Acalabrutinib Market Share by Country (2016-2027)
Figure 22. United States Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Acalabrutinib Market Share by Type (2016-2027)
Figure 26. Europe Acalabrutinib Market Share by Application (2016-2027)
Figure 27. Europe Acalabrutinib Market Share by Country (2016-2027)
Figure 28. Germany Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Acalabrutinib Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Acalabrutinib Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Acalabrutinib Market Share by Region (2016-2027)
Figure 38. China Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Acalabrutinib Market Share by Type (2016-2027)
Figure 46. Latin America Acalabrutinib Market Share by Application (2016-2027)
Figure 47. Latin America Acalabrutinib Market Share by Country (2016-2027)
Figure 48. Mexico Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Acalabrutinib Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Acalabrutinib Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Acalabrutinib Market Share by Country (2016-2027)
Figure 54. Turkey Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Acalabrutinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AstraZeneca Pharmaceuticals LP Revenue Growth Rate in Acalabrutinib Business (2016-2021)
Figure 58. Cephalon, Inc Revenue Growth Rate in Acalabrutinib Business (2016-2021)
Figure 59. Genentech, Inc Revenue Growth Rate in Acalabrutinib Business (2016-2021)
Figure 60. Cayman Chemical Company Revenue Growth Rate in Acalabrutinib Business (2016-2021)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

以下、関連資料のご紹介

世界のロミプロスティム市場規模・現状・予測（2021年-2027年）

Global Romiplostim Market Size, Status and Forecast 2021-2027
QFJ1-5998 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、ロミプロスティムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250μg/ 0.5mL、500μg/ 1mL）、用途別市場規模（成人、小児患者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界のデガレリクス市場規模・現状・予測（2021年-2027年）

Global Degarelix Market Size, Status and Forecast 2021-2027
QFJ1-5692 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、デガレリクスの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バイアル/120mg、バイアル/80mg）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のラパチニブ市場規模・現状・予測（2021年-2027年）

Global Lapatinib Market Size, Status and Forecast 2021-2027
QFJ1-5828 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、ラパチニブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250mg錠、タイプII）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界のアニデュラファンギン市場規模・現状・予測（2021年-2027年）

Global Anidulafungin Market Size, Status and Forecast 2021-2027
QFJ1-5581 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アニデュラファンギンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（50mg/各バイアル、100mg/各バイアル）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界のイクサベピロン市場規模・現状・予測（2021年-2027年）

Global Ixabepilone Market Size, Status and Forecast 2021-2027
QFJ1-5813 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、イクサベピロンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（15MG/VIAL、45MG/VIAL）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のヒストレリン市場規模・現状・予測（2021年-2027年）

Global Histrelin Market Size, Status and Forecast 2021-2027
QFJ1-5781 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、ヒストレリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（サプレリンLA、ヴァンタス）、用途別市場規模（男の子用、女の子用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のパニツムマブ市場規模・現状・予測（2021年-2027年）

Global Panitumumab Market Size, Status and Forecast 2021-2027
QFJ1-5929 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、パニツムマブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（100mg/5ml単回投与バイアル、400mg/20ml単回投与バイアル）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米...

世界のリスデキサンフェタミン市場規模・現状・予測（2021年-2027年）

Global Lisdexamfetamine Market Size, Status and Forecast 2021-2027
QFJ1-5832 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、リスデキサンフェタミンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、チュアブル錠）、用途別市場規模（成人ADHD、小児ADHD、成人B.E.D.）、主要地域別市場規模（北米、アメリカ、欧州...

世界のルビプロストン市場規模・現状・予測（2021年-2027年）

Global Lubiprostone Market Size, Status and Forecast 2021-2027
QFJ1-5835 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ルビプロストンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（8mcgカプセル、24mcgカプセル）、用途別市場規模（CIC・OIC、IBS-C）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界のレタパムリン市場規模・現状・予測（2021年-2027年）

Global Retapamulin Market Size, Status and Forecast 2021-2027
QFJ1-5992 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、レタパムリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（1％軟膏（15グラムチューブ）、1％軟膏（30グラムチューブ））、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ...

世界の研究室用水市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Laboratory Grade Water Market The global Laboratory Grade Water market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the repo…
世界のバイオ医薬品包装市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Biopharmaceutical Packaging Market The global Biopharmaceutical Packaging market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
世界のバイオ医薬品ラボ機器市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Biopharmaceutical Lab Equipment Market The global Biopharmaceutical Lab Equipment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…
世界のバイオ医薬品機器市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Biopharmaceutical Equipment Market The global Biopharmaceutical Equipment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
世界のバイオ医薬品処理装置＆消耗品市場規模・現状・予測（2021年-2027年） Biopharmaceutical Processing: Development, Design, and Implementation of Manufacturing Processes covers bioprocessing from cell line development to bulk drug substances.Biopharmaceutical Processing Equipment are kinds of Machinery used for biopharmaceutical processing. Market Analysis and Insights: …